Hellenic Dynamics (LSE:HELD) Debt-to-Equity: 0.43 (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hellenic Dynamics Debt-to-Equity?

Hellenic Dynamics LSE:HELD Debt-to-Equity is 0.43 as of Sep. 2023.

Hellenic Dynamics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was £0.08 Mil. Hellenic Dynamics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was £0.26 Mil. Hellenic Dynamics's Total Stockholders Equity for the quarter that ended in Sep. 2023 was £0.77 Mil. Hellenic Dynamics's debt to equity for the quarter that ended in Sep. 2023 was 0.43.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Hellenic Dynamics's Debt-to-Equity or its related term are showing as below:

LSE:HELD's Debt-to-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.28
* Ranked among companies with meaningful Debt-to-Equity only.

Hellenic Dynamics  (LSE:HELD) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Hellenic Dynamics Debt-to-Equity Related Terms

Hellenic Dynamics Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Hellenic Dynamics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hellenic Dynamics Debt-to-Equity Chart

Hellenic Dynamics Annual Data
Trend Dec19 Dec20
Debt-to-Equity
-32.00 -3.69

Hellenic Dynamics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Sep23
Debt-to-Equity Get a 7-Day Free Trial -3.69 N/A 0.80 1.10 0.43

LSE:HELD vs ZTS, NBIX, VTRS: Debt-to-Equity Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hellenic Dynamics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hellenic Dynamics Debt-to-Equity vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hellenic Dynamics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Hellenic Dynamics's Debt-to-Equity falls into.


Hellenic Dynamics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Hellenic Dynamics's Debt to Equity Ratio for the fiscal year that ended in Dec. 2020 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.031 + 0.345) / -0.102
=-3.69

Hellenic Dynamics's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.078 + 0.256) / 0.769
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.43 mean?
Hellenic Dynamics (LSE:HELD) has a Debt-to-Equity of 0.43 as of Sep. 2023. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Hellenic Dynamics and its competitors.
Is Hellenic Dynamics' Debt-to-Equity too high?
Hellenic Dynamics' current Debt-to-Equity is 0.43. The Drug Manufacturers industry median Debt-to-Equity is 0.28. Hellenic Dynamics' value of 0.43 is 53.6% above this industry median.
How does Hellenic Dynamics' Debt-to-Equity compare to ZTS and NBIX?
Hellenic Dynamics' Debt-to-Equity of 0.43 can be compared against companies in the Drug Manufacturers industry. The industry median Debt-to-Equity is 0.28. Hellenic Dynamics' value of 0.43 is 53.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Drug Manufacturers company?
The median Debt-to-Equity among Drug Manufacturers companies is 0.28, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hellenic Dynamics's current Debt-to-Equity of 0.43 is 53.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Hellenic Dynamics and its competitors. For the Drug Manufacturers industry, the median Debt-to-Equity is 0.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hellenic Dynamics's current Debt-to-Equity is 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hellenic Dynamics stock overvalued right now?
Hellenic Dynamics (LSE:HELD) has a current Debt-to-Equity of 0.43. The current Debt-to-Equity is 0.43 and 53.6% above the Drug Manufacturers industry median of 0.28. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Hellenic Dynamics (LSE:HELD), the current Debt-to-Equity is 0.43 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hellenic Dynamics Business Description

Address 3 Soothouse Spring, Suite 18 Stanta Business Centre, St. Albans, Hertfordshire, GBR, SW1A 1RN
Hellenic Dynamics PLC is engaged in the cultivation, and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers, destined for the growing medical cannabis markets across Europe.